Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates

Abstract Triple negative breast cancer (TNBC) accounts for about a fifth of all breast cancers and includes a diverse group of cancers. The heterogeneity of TNBC and the lack of target receptors on the cell surface make it difficult to develop specific therapeutic treatments. These aspects cause the...

Full description

Bibliographic Details
Main Authors: Gloria Bertoli, Claudia Cava, Fabio Corsi, Francesca Piccotti, Cristina Martelli, Luisa Ottobrini, Valentina Vaira, Isabella Castiglioni
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-85746-w

Similar Items

Similar Items